semaglutide patent Off-patent in 2026: the next revolution in anti-obesity medications Ozempic, Wegovy and Rybelsus: The

The promise of #GLP-1 receptor agonists for #neurodegenerative diseases Dilan Athauda @DilanAthauda et al

Patients face safety risks with counterfeit and compounded prescription weight-loss drugs Officials warn of counterfeit and compounding pharmacy concerns as demand for weight-loss medicines surges

Not research-grade powder

Wegovy works by mimicking a natural hormone in your body (GLP-1) that helps control appetite, reduce hunger, and support healthier eating habits

After a two-year-long shortage, the FDA announced that Eli Lillys GLP-1 drug Mounjaro, and obesity version Zepbound, are back in stock.

GLP-1 Nedir